Colorectal cancer is among the most commonly diagnosed cancers worldwide, affecting both men and women. It is particularly prevalent in developed countries, largely due to lifestyle and dietary factors.

Recent trends indicate a concerning increase in colorectal cancer among younger populations, even those under the age of 50. However, the risk still rises significantly with age, making individuals over 50 more vulnerable. Despite advances in medical science, colorectal cancer remains a leading cause of cancer-related deaths, highlighting the need for improved awareness, screening programs, and lifestyle modifications.

Understanding the risk factors of colorectal cancer is essential for prevention and early detection. These factors can be broadly classified into non-modifiable, modifiable, and medical conditions.

Non-Modifiable Factors

Certain risk factors cannot be changed but help identify high-risk individuals:

• Age: Risk increases significantly after 50
• Family history: A history of colorectal cancer in close relatives raises susceptibility
• Genetic syndromes: Conditions like Lynch syndrome and Familial Adenomatous Polyposis (FAP) greatly increase risk

 Modifiable Factors

Lifestyle choices play a crucial role in the development of colorectal cancer:

• Diet high in red and processed meats
• Low intake of fiber-rich foods
• Obesity and excess body weight
• Physical inactivity
• Smoking
• Excessive alcohol consumption

Adopting a healthier lifestyle can significantly reduce the risk of developing colorectal cancer.

3.3 Medical Conditions

Certain underlying health conditions also increase risk:

• Inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease
• Type 2 diabetes
• Previous history of colon polyps.

Colorectal cancer develops through a stepwise progression that begins in the inner lining of the colon or rectum.

Progression Pathway:

Normal mucosa → Adenoma (polyp) → Carcinoma

This transformation typically occurs over several years, providing a valuable window for early detection and intervention.

Genetic Mutations

Several genetic mutations play a key role in colorectal cancer development:

• APC gene mutation: Initiates polyp formation
• KRAS mutation: Promotes tumor growth
• TP53 mutation: Leads to malignant transformation

Molecular Pathways

Three major molecular pathways are involved:

• Chromosomal instability pathway
• Microsatellite instability pathway
• CpG island methylation pathway

Understanding these pathways helps in developing targeted therapies for colorectal cancer.

In the early stage, colorectal cancer may not show any noticeable symptoms, which is why regular screening is very important. As the disease develops, certain signs may begin to appear.

Common symptoms include:

• Ongoing changes in bowel habits, including diarrhea or constipation.
• Presence of blood in the stool or rectal bleeding
• Abdominal discomfort, pain, or cramps
• A feeling that the bowel is not completely emptied after passing stool
• Unexplained weight loss
• Weakness or fatigue caused by anemia

If any of these symptoms continue for more than a few weeks, medical advice should be sought. Detecting colorectal cancer early greatly increases the chances of successful treatment.

Screening plays a crucial role in reducing the mortality of colorectal cancer. It is generally recommended to begin screening at around age 45, or earlier for high-risk individuals.

Screening Methods:

• Colonoscopy (gold standard)
• Sigmoidoscopy
• Stool-based tests such as FIT, FOBT, and DNA tests

Importance of Screening:

• Detects precancerous polyps before they turn into cancer
• Enables early-stage diagnosis
• Significantly reduces mortality rates

At Kannappa Memorial Hospital, advanced screening protocols are implemented to ensure accurate and early detection of colorectal cancer.

Once colorectal cancer is suspected, a combination of clinical evaluation and diagnostic tests is used to confirm the diagnosis.

Diagnostic Tools:

• Colonoscopy with biopsy (definitive diagnosis)
• Imaging tests:
  • CT scan
  • MRI
  • PET scan
• Laboratory tests:
  • Blood tests
  • Tumor markers such as CEA (Carcinoembryonic Antigen)

Accurate diagnosis is essential for determining the stage and planning effective treatment.

Colorectal cancer staging helps doctors understand how far the cancer has spread in the body. This is important because it guides treatment decisions and helps predict outcomes.

Doctors use the TNM system, which looks at three key things:

• T (Tumor): Indicates the depth to which the tumor has invaded the wall of the colon or rectum.
• N (Nodes): Indicates whether cancer has reached nearby lymph nodes
• M (Metastasis): Shows if cancer has spread to distant organs

Stages of Colorectal Cancer:

• Stage 0: Cancer is limited to the inner lining of the colon or rectum
• Stage I: Cancer has grown into the wall but has not spread further
• Stage II: Cancer has spread deeper into the wall or nearby tissues
• Stage III: Cancer has spread to the nearby lymph nodes.
• Stage IV: Cancer has spread to distant organs, including the liver or lungs.

In simple terms, lower stages mean the cancer is more localized and easier to treat, while higher stages indicate more spread and require advanced treatment.

Understanding the stage of colorectal cancer helps doctors choose the best treatment and improve the chances of recovery.

Treatment of colorectal cancer depends on the stage, location, and overall health of the patient.

Surgery

Surgery is the primary treatment for localized colorectal cancer. It involves removal of the tumor and surrounding tissue.

Chemotherapy

Chemotherapy is used:

• After surgery to prevent recurrence
• In advanced stages to control disease progression

Radiotherapy

Radiotherapy is mainly used in rectal cancer, often before surgery to shrink tumors.

Targeted Therapy

Targeted drugs focus on specific molecular pathways involved in colorectal cancer growth, improving treatment precision.

Immunotherapy

Immunotherapy boosts the body’s immune system to fight cancer cells, especially in certain genetic types of colorectal cancer.

Kannappa Memorial Hospital offers a multidisciplinary approach, combining these therapies for optimal patient outcomes.

The prognosis of colorectal cancer largely depends on the stage at diagnosis.

• Early-stage detection → High survival rates
• Advanced-stage cancer → Lower survival rates

With advancements in treatment and early screening, survival rates have improved significantly in recent years.

Preventing colorectal cancer means reducing the risk of getting it and finding it early.

Primary Prevention (Healthy lifestyle)

This means doing things that keep your body healthy:

• Eat more fiber foods like fruits, vegetables, and whole grains
• Keep a healthy body weight
• Do regular exercise
• Do not smoke
• Drink less alcohol

 These habits help lower the chance of cancer developing.

 Secondary Prevention (Early detection)

This means finding cancer early before it becomes serious:

• Do regular screening tests (like colonoscopy)
• People with higher risk should be checked more often

 Early detection makes treatment easier and more successful.

Chemoprevention (Medicines)

Sometimes doctors may give medicines to reduce risk:

• Example: Aspirin (only for some high-risk people)
• Must be taken only under doctor supervision

If left untreated or diagnosed late, colorectal cancer can lead to serious complications, including:

• Intestinal obstruction
  • Tumor growth blocks the passage of stool through the colon or rectum.
• Metastasis (spread to other organs)
  • Cancer may spread to distant organs such as the liver, lungs, or lymph nodes.
• Recurrence
  • Cancer may return after treatment, either at the original site or elsewhere in the body.

Even with medical progress, some problems still exist in colorectal cancer care:

• Cancer is often found late because early symptoms are not obvious
• Not everyone has access to regular screening tests
• Some cancers become resistant to treatment over time
• There are differences in healthcare access, which affects patient outcomes

 These challenges can be reduced by improving awareness and healthcare services.

The future of colorectal cancer treatment looks better due to ongoing research:

• Personalized medicine based on a person’s genes
• Better understanding through genetic and molecular studies
• Improved and earlier screening methods
• New and more effective targeted therapies and immunotherapy

 These advancements will help detect cancer earlier and improve survival and quality of life.

Colorectal cancer is both preventable and treatable, especially when detected early. Increasing awareness, adopting a healthy lifestyle, and undergoing regular screening are key to reducing the burden of this disease.

Healthcare institutions like Kannappa Memorial Hospital play a vital role in providing comprehensive care, from early detection to advanced treatment options.By prioritizing prevention and timely intervention, we can significantly reduce the impact of colorectal cancer and improve patient outcomes worldwide.